Funder
Nihon Medi-Physics Co., Ltd
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine
Reference31 articles.
1. Kuhl DE, Barrio JR, Huang SC, Selin C, Ackermann RF, Lear JL, et al. Quantifying local cerebral blood flow by N-isopropyl-p-[123I] iodoamphetamine (IMP) tomography. J Nucl Med. 1982;23:196–203.
2. Mosconi L, Tsui WH, Herholz K, Pupi A, Drzezga A, Lucignani G, et al. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer’s disease, and other dementia. J Nucl Med. 2008;49:390–8.
3. Staffen W, Schonauer U, Zauner H, Spindler I, Mair A, Iglseder B, et al. Brain perfusion SPECT in patients with mild cognitive impairment and Alzheimer’s disease: comparison of a semiquantitative and a visual evaluation. J Neural Transm. 2006;113:195–203.
4. Chida K, Ogasawara K, Kuroda H, Aso K, Kobayashi M, Fujiwara S, et al. Central benzodiazepine receptor binding potential and CBF images on SPECT correlate with oxygen extraction fraction images on PET in the cerebral cortex with unilateral major cerebral artery occlusive disease. J Nucl Med. 2011;52:511–8.
5. Iida H, Ito H, Nakazawa M, Hatazawa J, Nishimura H, Onishi Y, et al. Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT. J Nucl Med. 1994;35(12):2019–30.